ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Diisopropylethylamine → [4,5-Bis-(4-chloro-phenyl)-2-(2-ethoxy-4-trifluoromethyl-phenyl)-4,5-dihydro-imidazol-1-yl]-[4-(morpholine-4-sulfonyl)-piperazin-1-yl]-methanone

HRID 31512
印刷

反応式

HRID 31512 の反応式
Cl.[N:2]1([S:8]([N:11]2[CH2:16][CH2:15][O:14][CH2:13][CH2:12]2)(=[O:10])=[O:9])[CH2:7][CH2:6][NH:5][CH2:4][CH2:3]1.C(N(C(C)C)CC)(C)C.[Cl:26][C:27]1[CH:32]=[CH:31][C:30]([CH:33]2[CH:37]([C:38]3[CH:43]=[CH:42][C:41]([Cl:44])=[CH:40][CH:39]=3)[N:36]([C:45](Cl)=[O:46])[C:35]([C:48]3[CH:53]=[CH:52][C:51]([C:54]([F:57])([F:56])[F:55])=[CH:50][C:49]=3[O:58][CH2:59][CH3:60])=[N:34]2)=[CH:29][CH:28]=1>C(Cl)Cl>[Cl:26][C:27]1[CH:32]=[CH:31][C:30]([CH:33]2[CH:37]([C:38]3[CH:39]=[CH:40][C:41]([Cl:44])=[CH:42][CH:43]=3)[N:36]([C:45]([N:5]3[CH2:4][CH2:3][N:2]([S:8]([N:11]4[CH2:12][CH2:13][O:14][CH2:15][CH2:16]4)(=[O:10])=[O:9])[CH2:7][CH2:6]3)=[O:46])[C:35]([C:48]3[CH:53]=[CH:52][C:51]([C:54]([F:55])([F:56])[F:57])=[CH:50][C:49]=3[O:58][CH2:59][CH3:60])=[N:34]2)=[CH:29][CH:28]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 81531DiisopropylethylamineHCID 428835964-(Piperazine-1-sulfonyl)morpholine hydrochlorideHCID 597928204,5-Bis-(4-chloro-phenyl)-2-(2-ethoxy-4-trifluoromethyl-phenyl)-4,5-dihydro-imidazole-1-carbonyl chloride

生成物 1

HCID 11331631[4,5-Bis-(4-chloro-phenyl)-2-(2-ethoxy-4-trifluoromethyl-phenyl)-4,5-dihydro-imidazol-1-yl]-[4-(morpholine-4-sulfonyl)-piperazin-1-yl]-methanone収率 64%

試薬・触媒・溶媒

1
HCID 6344Dichloromethane溶媒2 回

実験手順

4-(Piperazine-1-sulfonyl)-morpholine hydrochloride (0.042 mmol) was suspended in methylene chloride, and 400 uL of diisopropylethylamine was added. The mixture was added to 4,5-bis-(4-chloro-phenyl)-2-(2-ethoxy-4-trifluoromethyl-phenyl)-4,5-dihydro-imidazole-1-carbonyl chloride (10 mg, 0.019 mmol, example 3), and the reaction mixture was allowed to stand overnight. It was diluted with methylene chloride and washed with water. The organic layer was evaporated, and the residue purified by flash chromatography using ethyl acetate and hexanes to give [4,5-bis-(4-chloro-phenyl)-2-(2-ethoxy-4-trifluoromethyl-phenyl)-4,5-dihydro-imidazol-1-yl]-[4-(morpholine-4-sulfonyl)-piperazin-1-yl]-methanone (9.0 mg). LR-MS: 740.2 [(M+H)+].

後処理

  1. washwashed with water
  2. customThe organic layer was evaporated
  3. customthe residue purified by flash chromatography

出典と根拠

ORDレコード
ord-68e972d2171d432ba1d7f375ca42e363
出典データセット
uspto-grants-2008_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07425638B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート